Impaired vibration perception threshold and long-term mean HbA(1c) in patients with type 1 diabetes mellitus

Diabetic Medicine

Volumn 13, Issue 12, 1996, Pages 1027-1032

  Kullberg, C E ^a,b   Arnqvist, H J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Diabetic neuropathy; Glycaemic control; HbA(1c); Type 1 (insulin dependent) diabetes mellitus; Vibration perception

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; VIBRATION;

ADULT; AGE FACTORS; AGE OF ONSET; ALBUMINURIA; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SENSORY THRESHOLDS; SMOKING; TIME FACTORS; TRIGLYCERIDES; VIBRATION;

EID: 0029908140     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199612)13:12<1027::AID-DIA275>3.0.CO;2-N     Document Type: Article

References (27)

1. Parving H-H, Hommel E, Mathiesen E, Skott P, Edsberg B, Bahnsen M. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in patients with insulin dependent diabetes. Br Med J 1988; 296: 156-160.
2. Jakobsen J, Christiansen JS, Kristoffersen I, Christensen CK, Hermansen K, Schmitz A. Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in Type 1 diabetes. Diabetes 1988; 37: 452-455.
3. Lauritzen T, Frost-Larsen K, Larsen H-W, Deckert T, the Steno Study Group. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985; 34 (suppl): 74-79.
4. Maser RE, Becker DJ, Drash AL, Ellis D, Kuller LH, Greene DA. Pittsburgh epidemiology of diabetes complications study. Measuring diabetic neuropathy. Follow-up results. Diabetes Care 1992; 15: 525-527.
5. Valensi P, Attali J-R, Gagant S, The French Group for Research and Study of Diabetic Neuropathy. Reproducibility of parameters for assessment of diabetic neuropathy. Diabetic Med 1993; 10: 933-939.
6. Young MJ, Veves A, Breddy JL, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. Diabetes Care 1994; 17: 557-560.
7. Reichard P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-309.
8. Wiles PG, Pearce SM, Rice PJS, Mitchell JMO. Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabetic Med 1991; 8: 157-161.
9. Kullberg CE, Arnqvist HJ. Elevated long-term glycated haemoglobin precedes proliferative retinopathy and nephropathy in Type 1 (insulin-dependent) diabetes. Diabetologia 1993; 36: 961-965.
10. Kullberg CE, Arnqvist HJ. Good blood glucose control characterizes patients without retinopathy after long diabetes duration. Diabetic Med 1995; 12: 314-320.
11. Olsen BS, Nir M, Kjaer I, Volund A, Mortensen HB. Elevated vibration perception threshold in young patients with Type 1 diabetes in comparison to non-diabetic children and adolescents. Diabetic Med 1994; 11: 888-892.
12. McKillop GM, Jamal GA, Kesson CM. Vibration perception thresholds in 279 diabetic patients. Scott Med J 1988; 33: 334-335.
13. Boulton AJM, Knight G, Drury J, Ward JD. The prevalence of symptomatic, diabetic neuropathy in an insulin-treated population. Diabetes Care 1985; 8: 125-128.
14. Donaghue KC, Bonney M, Simpson JM, Schwingshandl J, Fung ATW, Howard NJ. Autonomic and peripheral nerve function in adolescents with and without diabetes. Diabetic Med 1993; 10: 664-671.
15. Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Keirulf P, Smeland E. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J 1986; 293: 1195-1199.
16. Duck SC, Lei F, Parke J, Swick HM. Role of height and glycosylated hemoglobin in abnormal nerve conduction in pediatric patients with Type 1 diabetes mellitus after 4-9 yr of disease. Diabetes Care 1991; 14: 386-392.
17. Maser RE, Steenkiste AR, Dorman JS, Kamp Nielsen V, Bass BE, Manjoo Q. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38: 1456-1461.
18. Barzilary J, Warram JH, Rand LI, Pfeifer MA, Krolewski AS. Risk for cardiovascular autonomic neuropathy is associated with the HLA/DR 3/4 phenotype in type 1 diabetes mellitus. Ann Int Med 1992; 116: 544-549.
19. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
20. Armstrong FM, Bradbury JE, Ellis SH, Owens DR, Rosen I, Sonksen P. A study of peripheral diabetic neuropathy. The application of age-related reference values. Diabetic Med 1991; 8: S94-S99.
21. Larkins RG, Dunlop ME. The link between hyperglycaemia and diabetic nephropathy. Diabetologia 1992; 35: 499-504.
22. Kullberg CE, Finström K, Arnqvist HJ. Severity of background retinopathy in Type 1 diabetes increases with the level of long-term glycated haemoglobin. Acta Ophthalmol 1994; 72: 181-188.
23. Bodmer CW, Masson EA, Savage MW, Benbow S, Patrick AW, Williams G. Asymptomatic peripheral nerve dysfunction and vascular reactivity in IDDM patients with and without microalbuminuria. Diabetologia 1994; 37: 1056-1061.
24. Beisswenger PJ, Moore LL, Curphey TJ. Relationship between glycemic control and collagen-linked advanced glycosylation end products in type 1 diabetes. Diabetes Care 1993; 16: 689-694.
25. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321.
26. Masson EA, Boulton AJM. Calibration problems with the biothesiometer. Diabetic Med 1990; 7: 261-262.
27. Zeigler D, Gries FA, Spuuler M, Lessmann F, and the DiaCAN Multicenter Study Group. The epidemiology of neuropathy. Diabetic Med 1993; 10 (suppl 2): 82S-86S.